首页> 美国卫生研究院文献>Cancer Medicine >The role of microRNA‐93 regulating angiopoietin2 in the formation of malignant pleural effusion
【2h】

The role of microRNA‐93 regulating angiopoietin2 in the formation of malignant pleural effusion

机译:microRNA‐93调节血管生成素2在恶性胸腔积液形成中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The biological roles of miRNAs in the development of malignant pleural effusion (MPE) are unclear. In this study, the miRNA microarray analysis was performed in two different prognosis groups of lung adenocarcinoma patients. Expression profiles of miRNAs in MPEs were identified. With the help of quantification PCR, we confirmed the expression differences of miRNAs and further analyzed their biological functions and relative target genes in vitro. The target gene of miR‐93 was estimated by online database, and also, the protein was tested. The target gene and the binding sites of specific miRNA were estimated by online database. The combining capacity of binding sites was verified by luciferase reporter gene assay, and the target gene protein was tested by western blot. We detected 107 miRNAs with expression differences (n = 10) and confirmed significant expression differences in miR‐93 and miR‐146a in two groups of patients (n = 84). By manipulating miR‐93 expression of human lymphatic endothelial cells (HLEC) and human umbilical vein endothelial cells (HUVEC), we discovered that high expression of miR‐93 inhibited migration, proliferation, and angiogenesis. And also, miR‐93 increased not only apoptosis, but also G1 phase cell block. By using luciferase reporter gene assay and western blot, we confirmed that angiopoietin2 (Ang2) was the target of miR‐93. The data showed that miR‐93 has an inhibiting effect on pleural effusion. By targeting Ang2, miR‐93 regulates angiogenesis and lymphangiogenesis and plays a role in pathogenetic mechanism of MPE. MiR‐93/Ang2 may shed light on potential new targets in cancer treatment.
机译:miRNA在恶性胸腔积液(MPE)发生中的生物学作用尚不清楚。在这项研究中,在两个不同的肺腺癌预后组中进行了miRNA芯片分析。鉴定了miRNA在MPE中的表达谱。借助定量PCR,我们确认了miRNA的表达差异,并进一步分析了它们的生物学功能和相关靶基因。通过在线数据库估算了miR-93的靶基因,并对蛋白质进行了测试。通过在线数据库估计靶基因和特异性miRNA的结合位点。结合位点的结合能力通过萤光素酶报告基因检测得到证实,目标基因蛋白通过western blot检测。我们检测到107个表达差异(n = 10)的miRNA,并确认两组患者(n = 84)在miR-93和miR-146a中存在明显的表达差异。通过操纵人淋巴管内皮细胞(HLEC)和人脐静脉内皮细胞(HUVEC)的miR-93表达,我们发现miR-93的高表达抑制了迁移,增殖和血管生成。而且,miR-93不仅增加凋亡,而且增加G1期细胞阻滞。通过使用荧光素酶报告基因检测和Western印迹,我们证实血管生成素2(Ang2)是miR-93的靶标。数据显示,miR-93对胸腔积液有抑制作用。通过靶向Ang2,miR-93调节血管生成和淋巴管生成,并在MPE的致病机制中起作用。 MiR-93 / Ang2可能会揭示癌症治疗中潜在的新靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号